Processa CEO buys 1,843 common shares
Processa Pharmaceuticals, Inc. Chief Executive Officer George K. Ng bought additional company stock in the open market.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Processa Pharmaceuticals, Inc. Chief Executive Officer George K. Ng bought additional company stock in the open market. He purchased 1,843 shares of common stock at $2.97 per share, bringing his directly held position to 5,492 shares. The filing also lists indirect holdings of 3,488 shares held under "George Ng IRRA FOB George Ng" and 800 shares held through the "Ng Cha Family Trust," showing both personal and related-entity ownership of Processa common stock.
Insider Trade Summary
Net Buyer: 1,843 shares
Net Buy
3 txns
Insider
Ng George K
Role
Chief Executive Officer
Bought
1,843 shs ($5K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 1,843 | $2.97 | $5K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 5,492 shares (Direct);
Common Stock — 3,488 shares (Indirect, George Ng IRRA FOB George Ng);
Common Stock — 800 shares (Indirect, Ng Cha Family Trust)
Key Figures
Open-market purchase: 1,843 shares
Purchase price: $2.97 per share
Direct holdings after: 5,492 shares
+2 more
5 metrics
Open-market purchase
1,843 shares
Common Stock bought by CEO George K. Ng
Purchase price
$2.97 per share
Price paid for 1,843 Processa common shares
Direct holdings after
5,492 shares
Common Stock directly owned by CEO after transaction
Indirect IRRA holdings
3,488 shares
Indirect ownership via "George Ng IRRA FOB George Ng"
Indirect trust holdings
800 shares
Indirect ownership via "Ng Cha Family Trust"
Key Terms
open-market purchase, Common Stock, indirect holdings, Form 4, +1 more
5 terms
open-market purchase financial
"He purchased 1,843 shares of common stock at $2.97 per share"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
Common Stock financial
"He purchased 1,843 shares of common stock at $2.97 per share"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
indirect holdings financial
"The filing also lists indirect holdings of 3,488 shares"
Form 4 regulatory
"The filing also lists indirect holdings of 3,488 shares"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
beneficial ownership financial
"showing both personal and related-entity ownership of Processa common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Processa Pharmaceuticals (PCSA) CEO George Ng do in this insider trade?
Processa CEO George K. Ng bought 1,843 shares of common stock in an open-market transaction. He paid $2.97 per share, increasing his directly owned stake to 5,492 shares. The filing also discloses additional indirect holdings through related entities.
What type of insider transaction was reported for Processa Pharmaceuticals (PCSA)?
The transaction is an open-market purchase of common stock by CEO George K. Ng. It is classified with code P, indicating a purchase, and involves 1,843 shares at $2.97 each, increasing his direct ownership position in the company.
Are there any derivative securities involved in this Processa Pharmaceuticals insider filing?
No derivative transactions are listed in this disclosure. The filing shows only common stock positions, including the CEO’s open-market purchase of 1,843 shares and his direct and indirect common share holdings, with the derivative securities section reported as empty.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates